🇺🇸 Genotypic resistance guided therapy in United States

Genotypic resistance guided therapy (Genotypic resistance guided therapy) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Genotypic resistance guided therapy in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Genotypic resistance guided therapy approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Genotypic resistance guided therapy in United States?

National Taiwan University Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.